Public-registry site landscape for NCT04135495, a Cystic Fibrosis study sponsored by Eloxx Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04135495 (registry record) |
| Sponsor | Eloxx Pharmaceuticals, Inc. |
| Condition(s) | Cystic Fibrosis |
| Phase | PHASE2 |
| Listed sites | 10 |
| Site countries | United States, Canada |
Eichor generates a preliminary site-risk snapshot for NCT04135495 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →